US 10450585
Delivery methods and compositions for nuclease-mediated genome engineering
granted A61KA61K2239/29A61K38/37
Quick answer
US patent 10450585 (Delivery methods and compositions for nuclease-mediated genome engineering) held by Sangamo Therapeutics, Inc. expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2239/29, A61K38/37, A61K38/4846, A61K40/11